You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
白云山(00874.HK)拟分拆广州医药于港交所上市
格隆汇 09-10 19:52

格隆汇9月10日丨白云山(00874.HK)发布公告,本公司董事会宣布于其2019年9月10日举行的会议上已审议并批准授权本公司管理层启动分拆广州医药有限公司(医药公司)并于香港联合交易所有限公司境外上市的前期筹备工作的议案。

据悉,医药公司于1951年在中国注册成立。截至本公告日期,本公司与联合美华有限公司分别持有医药公司80%及20%的股份。医药公司主要从事西药批发;药品零售;中成药、中药饮片批发;中药饮片零售;化学药制剂、生物制品(含疫苗)批发;医疗用品及器材零售(不含药品及医疗器械)等。

公司称,鉴于建议分拆及上市事项较为复杂,涉及的内外部审批程序较多,为保证工作顺利进行,本公司董事会授权本公司管理层启动建议分拆及上市的前期筹备工作,其中包括但不限于可行性方案的论证、中介机构的选聘、战略投资者的引入(若有)、组织编制上市方案及申请材料、签署筹划过程中涉及的相关协议等上市相关事宜,并在制定建议分拆及上市方案后将方案及与上市有关的其他事项分别提交本公司董事会、股东大会审议。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account